Clinical Trial Update: The COMACS Study: A Comparison of Methylphenidates in an Analog Classroom Setting [Phase 4]

View source ↗

Summary

An update on the COMACS study reports the completion of a Phase 4 trial comparing methylphenidate formulations in an analog classroom setting for Attention Defi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• CONCERTA (METHYLPHENIDATE HYDROCHLORIDE)
• Methylphenidate (generic) (methylphenidate)
• Ritalin (methylphenidate)

Snippet

Sponsor: UCB Pharma | Conditions: Attention Deficit Hyperactivity Disorder | Phase 4 | Status: COMPLETED